Regenxbio Inc.: Mizuho initiates coverage with outperform rating; target price $22.00
RGNX•Mizuho initiated coverage of Regenxbio with an outperform rating and a $22.00 target price.
Related News
Integra LifeSciences Holdings Corporation: BMO cuts target price to $15 from $18
IART•
Bright Horizons Family Solutions: BMO cuts target price to $83 from $93
BFAM•
ConocoPhillips says no decision yet on North Sea offer
COP•
DoubleVerify, OpenAI develop brand suitability evaluation pilot for ChatGPT ads
DV•
ECARX completes acquisition of Flyme software business for RMB 1.8 billion
ECX•